When patients with atopic dermatitis have increased phosphodiesterase activity, can we assume that beta-blockers might aggravate not only atopic dermatitis but also other eczematous dermatoses?

These data do not support an increased risk for adverse outcomes associated with concomitant ceftriaxone and calcium infusions in adult critically ill patients; however, our study was limited by ...